Australia markets closed

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
189.79+5.98 (+3.25%)
At close: 04:00PM EST
190.80 +1.01 (+0.53%)
After hours: 07:01PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
592,661
366,260
270,245
194,032
Cost of revenue
245,395
156,634
119,099
86,531
Gross profit
347,266
209,626
151,146
107,501
Operating expenses
Research development
31,877
20,182
19,450
15,821
Selling general and administrative
168,153
119,621
95,613
65,692
Total operating expenses
200,030
139,803
115,063
81,513
Operating income or loss
147,236
69,823
36,083
25,988
Interest expense
12,571
12,133
9,292
6,709
Total other income/expenses net
-1,192
1,527
-640
2,157
Income before tax
133,473
59,217
26,151
21,436
Income tax expense
14,594
-709
4,740
4,819
Income from continuing operations
118,879
59,926
21,411
16,617
Net income
118,879
59,926
21,411
16,617
Net income available to common shareholders
118,879
59,926
21,411
16,617
Basic EPS
-
1.14
0.44
0.38
Diluted EPS
-
1.11
0.44
0.37
Basic average shares
-
52,554
48,343
43,767
Diluted average shares
-
53,892
49,206
45,471
EBITDA
-
98,417
56,311
43,923